Мы используем Cookies Этот веб-сайт использует cookie-файлы, чтобы предлагать вам наиболее актуальную информацию. Просматривая этот веб-сайт, Вы принимаете cookie-файлы.
Знаете ли вы? Кликните два раза на слово, чтобы найти его в TermGallery.
Значения термина lose patent на английском
Значения для термина "lose patent" отсутствуют.
Использование термина lose patent на английском
1
Its Namenda Alzheimer's drug is set to losepatent protection in 2015.
2
He noted that other Pfizer drugs will also losepatent protection soon after Lipitor.
3
Lundbeck's most important drug will losepatent protection in 2012.
4
Its Namenda Alzheimer's drug will losepatent protection in 2015.
5
Lilly needs new drugs to offset declining sales of its older drugs as they losepatent protection.
6
Bristol-Myers and Lilly both need new products to replace their current top-selling medicines which will soon losepatent protection.
7
Its original blockbuster drug Tracleer is about to losepatent protection, although sales of new product Opsumit are growing.
8
Lexapro, which represents more than half of the company's revenue, is due to losepatent protection early next year.
9
By 2012, most key drugs will losepatent protection, including its two top-sellers, the blood-thinner Plavix and anti-thrombotic Lovenox.
10
The drug is expected to losepatent protection in September 2017, according to the lawsuit, further limiting its prospects.
11
Forest is expected to losepatent protection on Lexapro, the blockbuster antidepressant that is its top-selling drug, in early 2012.
12
Most pharma companies are increasingly focused on developing niche drugs for complex disorders as several mass market drugs losepatent protection.
13
The use of generic drugs has dramatically increased in recent years, as blockbuster drugs losepatent protection and healthcare costs rise.
14
The drug industry overall is suffering as older products losepatent protection and governments and health insurers push back on pricing.
15
By 2012, most of the group's key products will losepatent protection, including its two top-sellers, the blood-thinner Plavix and anti-thrombotic Lovenox.
16
Cubist may losepatent protection for Cubicin earlier than expected, after a Friday federal court ruling that invalidated four of its patents.